• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NUVASIVE INC. SIMPLIFY CERVICAL ARTIFICIAL DISC; PROSTHESIS INTERVERTEBRAL DISC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NUVASIVE INC. SIMPLIFY CERVICAL ARTIFICIAL DISC; PROSTHESIS INTERVERTEBRAL DISC Back to Search Results
Model Number SM-4
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Extraskeletal ossification (1428)
Date of Event 06/20/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
No device malfunction was alleged and remains in-situ, radiographs provided confirm the reported event.Review of the reported event noted no device problem alleged and that the patient experienced auto-fusion which is a known complication with intervertebral prosthesis and considered the result of the patients continued pathology.No device malfunction was identified or suggested.No additional investigation required.Manufacturing review: review of the device history records of all devices notes no material non-conformance¿s, no manufacturing errors, nor discrepancies with respect to material type, treatments, dimensions that may have caused or contributed to this mode of failure.Parts met acceptance criteria upon release.Labeling review: "warnings simplify cervical artificial disc should only be used by surgeons who are experienced with anterior cervical spinal procedures and have undergone hands-on training in the use of this device.Only surgeons who are familiar with simplify cervical artificial disc components, instruments, procedure, clinical applications, biomechanics, adverse events (aes), and risks associated with simplify cervical artificial disc should use this device.A lack of adequate experience and/or training may lead to a higher incidence of aes, including neurological complications.Correct selection of the appropriate implant size and correct placement of simplify cervical artificial disc are essential to ensure proper performance and functioning of the device.Information regarding implant size selection and correct implant placement is provided in the simplify cervical artificial disc surgical technique guide." "preoperative: in order to minimize the risk of atraumatic periprosthetic vertebral fractures, surgeons must consider all comorbidities, past and present medications, previous treatments, etc.Upon reviewing all relevant information, the surgeon must determine whether a bone density (dexa) scan is prudent.If dexa is performed, the patient should not receive the device if the dexa bone mineral density t-score is <-1.5, as the patient may be osteoporotic or osteopenic.Patient selection is extremely important.In selecting patients for a total disc replacement, the following factors can be of extreme importance to the success of the procedure: the patient¿s occupation or activity level; a condition of senility, mental illness, alcoholism or drug abuse; certain degenerative diseases that may be so advanced at the time of implantation that the expected useful life of the device is substantially decreased, and medical conditions that may affect postoperative management, such as alzheimer¿s disease and emphysema.The patient should be informed of the potential adverse effects (risks/complications) contained in this insert (see safety results / aes).Information on the proper implant site preparation, implant size selection, and the use of surgical instrumentation for the simplify cervical artificial disc is provided in the surgical technique guide and should be reviewed prior to surgery.Preoperative planning may be used to estimate the required implant size and to assure that the appropriate range of sizes is available for surgery.Correct selection of the appropriate implant sizes is extremely important to assure the placement and function." "cervical artificial disc risks specific to cervical artificial discs, including the simplify® cervical artificial disc, are but may not be limited to: spontaneous fusion due to heterotopic ossification, development of bridging bone or osteophytes." 32226-e-2023-03.
 
Event or Problem Description
This complaint was identified during review of the sm2 simplify disc 2 level study report that noted on (b)(6) 2018, a patient underwent a cervical total disc replacement at c6/7.On (b)(6) 2024, the patient was presented at the 72 week follow up with spontaneous fusion at the c6/7 index level and noted as heterotopic ossification, but no treatment has been provided as it was considered a permanent auto-fusion and the patient will continue to be monitored.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SIMPLIFY CERVICAL ARTIFICIAL DISC
Common Device Name
PROSTHESIS INTERVERTEBRAL DISC
Manufacturer (Section D)
NUVASIVE INC.
7475 lusk blvd.
san diego CA 92121
Manufacturer (Section G)
NUVASIVE INC.
7475 lusk blvd.
san diego CA 92121
Manufacturer Contact
whitney ginter
7475 lusk blvd.
san diego, CA 92121
MDR Report Key20913793
Report Number2031966-2024-00337
Device Sequence Number7787890
Product Code MJO
UDI-Device Identifier00843285100009
UDI-Public843285100009
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P200022
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 12/12/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date07/31/2021
Device Model NumberSM-4
Device Lot Number3345
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/03/2024
Initial Report FDA Received Date12/12/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/18/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age71 YR
Patient SexFemale
-
-